Harrow Inc (HROW)
10.38
-0.26
(-2.44%)
USD |
NASDAQ |
May 03, 16:00
10.38
0.00 (0.00%)
After-Hours: 20:00
Harrow 1 Year Total Returns (Daily): -59.28% for May 3, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 03, 2024 | -59.28% |
May 02, 2024 | -58.45% |
May 01, 2024 | -59.67% |
April 30, 2024 | -59.61% |
April 29, 2024 | -57.91% |
April 26, 2024 | -57.69% |
April 25, 2024 | -58.59% |
April 24, 2024 | -59.29% |
April 23, 2024 | -58.10% |
April 22, 2024 | -56.96% |
April 19, 2024 | -55.53% |
April 18, 2024 | -54.12% |
April 17, 2024 | -49.16% |
April 16, 2024 | -43.94% |
April 15, 2024 | -43.71% |
April 12, 2024 | -42.97% |
April 11, 2024 | -42.43% |
April 10, 2024 | -45.07% |
April 09, 2024 | -42.31% |
April 08, 2024 | -42.31% |
April 05, 2024 | -36.66% |
April 04, 2024 | -38.18% |
April 03, 2024 | -37.53% |
April 02, 2024 | -41.49% |
April 01, 2024 | -39.51% |
Date | Value |
---|---|
March 28, 2024 | -37.68% |
March 27, 2024 | -40.68% |
March 26, 2024 | -31.70% |
March 25, 2024 | -34.85% |
March 22, 2024 | -33.41% |
March 21, 2024 | -41.32% |
March 20, 2024 | -39.37% |
March 19, 2024 | -38.65% |
March 18, 2024 | -39.57% |
March 15, 2024 | -39.68% |
March 14, 2024 | -45.71% |
March 13, 2024 | -42.03% |
March 12, 2024 | -40.70% |
March 11, 2024 | -40.25% |
March 08, 2024 | -41.16% |
March 07, 2024 | -38.89% |
March 06, 2024 | -38.57% |
March 05, 2024 | -40.57% |
March 04, 2024 | -39.92% |
March 01, 2024 | -40.33% |
February 29, 2024 | -39.59% |
February 28, 2024 | -38.95% |
February 27, 2024 | -31.34% |
February 26, 2024 | -33.90% |
February 23, 2024 | -35.53% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-59.67%
Minimum
May 01 2024
359.6%
Maximum
May 11 2023
46.64%
Average
22.57%
Median
Jan 17 2020
1 Year Total Returns (Daily) Benchmarks
Aquestive Therapeutics Inc | 109.5% |
Cyclacel Pharmaceuticals Inc | -75.76% |
Lifecore Biomedical Inc | 45.23% |
Relmada Therapeutics Inc | 35.29% |
Corvus Pharmaceuticals Inc | 69.91% |